The Luigi Mangione Trial, Explained: Why America Can't Look Away

June 3, 2026 15 min read
Share

Prosecutors in New York City are preparing for a showdown in what is likely to become one of the most-watched trials of the decade. They are wrestling with the defense attorneys of Luigi Mangione, the man charged with the murder of Brian Thompson, the chief executive of UnitedHealthcare, in early December 2024. Ever since it happened, the killing and Mangione’s fate have generated fierce controversy across the United States, all wrapped up in a far larger argument about America’s broken healthcare system.

As of mid-2026, Mangione faces more than a dozen charges from two US states and the federal government, and his trial has all the makings of a media circus. A young man captured five days after the shooting has become, depending on where you look, a folk hero, a misguided criminal, or a cold-blooded terrorist — and the legal proceedings around him have turned into a referendum on something far bigger than a single death.

Here is what you need to know before the trial begins, and what to expect once it finally gets underway. The case sits at the intersection of national politics, justice, economics, healthcare, and radicalization — and a verdict in either direction may speak to questions that reach well beyond a Manhattan courtroom.

Key Takeaways

  • Brian Thompson, the CEO of UnitedHealthcare — America’s largest health insurer — was shot and killed outside a Midtown Manhattan hotel on the morning of December 4, 2024.
  • Luigi Mangione, who was 27 at the time, was arrested five days later at a McDonald’s roughly 450 kilometers from New York City; he and his legal team have pleaded not guilty to all charges.
  • The bullet casings recovered at the scene were etched with the words “delay,” “deny,” and “depose” — language widely associated with insurer claim denials.
  • Mangione now faces second-degree murder and eight weapons counts in New York, a separate set of federal charges, and additional charges in Pennsylvania where he was apprehended.
  • Federal prosecutors, on the instruction of US Attorney General Pam Bondi, are seeking the death penalty; the state-level charges carry up to life imprisonment.
  • Public reaction has been unusually sympathetic to Mangione, particularly among young people, with crowdfunding for his defense topping a million dollars.
  • A pretrial fight over what evidence will be admissible could shape whether Mangione is convicted on all counts or evades at least some of the charges.

The Morning of December 4, 2024

The scene was outside the Hilton hotel in Midtown Manhattan, New York City. The time was 6:44 in the morning, and Brian Thompson, the CEO of America’s largest health insurer, was walking into the hotel for an investors’ meeting. Across the street, a masked, hooded assailant stood waiting for Thompson to arrive, then crossed as Thompson came close.

In an act captured on CCTV and shared widely across the globe afterward, Thompson was shot from behind three times from a distance of about six meters, using a suppressed nine-millimeter pistol. That pistol would later be revealed to be a so-called ghost gun, built largely from 3D-printed parts manufactured using instructions that can be easily accessed online.

The shooter did not wait around. He departed the scene on an e-bike and, while passing through Central Park, left behind a backpack stuffed with fake money from the board game Monopoly. He then left the city. Soon after, forensic investigators found another signature element of the killing: three bullet casings, onto which the suspect had etched the words “delay,” “deny,” and “depose.” Brian Thompson, the victim, was pronounced dead at 7:12 AM at Mount Sinai Hospital.

A Killing the Country Could Not Ignore

Thompson’s death became national news in the United States almost immediately, with push notifications rolling in from news sites by mid-morning. Even though a suspect would not be arrested for another five days, many Americans could very easily guess the kind of motivation a person might have for shooting Thompson.

A crucial caveat belongs here, the same one so many outside analysts have issued when discussing this case: murder is wrong. The fact that the public could guess at a motive does not mean most Americans endorsed the killing. But the reason the motive felt so legible had much less to do with Thompson himself — who had worked for UnitedHealthcare for over two decades yet was far from a public-facing figure — and much more to do with the company he represented.

Watch on HomeFronts

Watch the full video analysis on the HomeFronts YouTube channel, presented by Simon Whistler.

UnitedHealthcare is part of a corporation known as UnitedHealth Group. It is not only the United States’ largest health insurer, but the largest healthcare company in the world, and one of the ten largest companies of any kind anywhere. As such, it is the single biggest private player in the American healthcare system — a system that, by broad agreement, is in deep trouble.

A System Most Americans Already Resent

In a hyper-polarized United States, Americans across the spectrum still manage to agree on at least one thing: that whatever good doctors and local health infrastructure they might personally be able to access, the broader system is failing them. It has been ravaged by exorbitantly high prices, and insurers — especially UnitedHealth Group — are seen as bearing a large share of the blame.

In the United States, healthcare is treated as a business, not a human right. With free rein to extract profit from people in need of treatment, private insurers and a tangle of other corporate interests make sure to take their cut. Care can be denied, and insurers are incentivized to avoid spending on patient well-being unless it cannot be avoided. That structural reality is the backdrop against which a single shooting became a national flashpoint, rather than a discrete crime story.

This is why the language on those bullet casings landed so hard. Two of the three etched words — “delay” and “deny” — were already painfully familiar to patients and healthcare professionals who have worked with UnitedHealth Group, and who regularly allege that their insurance claims are delayed as long as possible, or outright denied whenever the insurer can manage it.

The Allegations Against UnitedHealth Group

Even within a bloated, broken system, UnitedHealth Group had developed a particular reputation by the time of the Manhattan shooting. It is well known for allegations that it denies treatments, surgeries, medications, and other measures deemed necessary by doctors — allegedly quite regularly, and often for opaque reasons.

The company has been accused of trying to steer patients into its own subsidiary companies, of requiring health organizations to avoid competing over physicians, and of engaging in stock-manipulation schemes for the alleged benefit of its executives. It has been investigated for defrauding consumers on numerous occasions, for overbilling the United States’ Medicare system by sums estimated in the millions of dollars, and for attempting to monopolize the US healthcare industry.

Even since Thompson’s death in late 2024, the scrutiny has continued. A Guardian investigation accused UnitedHealth Group of systematically paying off nursing homes so that they would not transfer residents to hospitals — even when those residents needed hospital care — and of pressuring those nursing homes into signing do-not-resuscitate agreements for their patients. The organization has also developed a habit of legally threatening journalists and healthcare professionals who criticize it. It is worth stating plainly that all of these are allegations, presented here as such and not as settled fact.

A Suspect Who Became a Folk Hero

The reason all of this matters is that, even before a suspect was in custody, a fair number of Americans had already made clear that they did not exactly disapprove of the broader sentiment behind the killing. The vast majority took pains to reiterate that shooting and killing Thompson was unequivocally wrong. But that did not stop many of those same people from expressing rage they, or people in their lives, had felt toward UnitedHealth Group, sometimes for years.

When UnitedHealth Group posted a statement on Facebook in the wake of the shooting, it was bombarded with over a hundred thousand laughing emojis in its reactions. Public polling by the University of Chicago found that nearly seventy percent of respondents felt insurance claim denials, or the profiteering of insurance companies, were largely responsible for deaths.

Once the suspect — Luigi Mangione — was captured and identified, the reaction only intensified. In some corners, Mangione turned into something of a folk hero. The favorable reception was especially pronounced among young people: a poll by Emerson College found that a full forty-one percent of young respondents found the killing to be “acceptable or somewhat acceptable.” Online crowdfunding initiatives have set aside over a million dollars to aid in Mangione’s legal defense, and his likeness and the messages attributed to him have become widespread, especially in some of America’s biggest cities.

What Investigators Say They Found

Mangione was captured five days after the killing, at a McDonald’s restaurant about 450 kilometers from New York City. According to police, he was found with a 3D-printed gun and suppressor on his person, as well as a fake driver’s license that had been used in a Manhattan hostel in late November, and a short handwritten statement.

According to transcripts released by law enforcement, Mangione wrote, among other messages: “Frankly, these parasites simply had it coming […] they continue to abuse our country for immense profit because the American public has [allowed] the, to get away with it.” Prosecutors allege that his diary entries referred to “the deadly, greed fueled health insurance cartel,” and that he praised another highly controversial American killer, the Unabomber.

Adding to his alleged motive, investigators have noted that Mangione suffered from chronic pain after a back injury and a complex surgery, as well as Lyme disease — although he was never personally insured by UnitedHealth Group. It bears repeating that, like the allegations against the company, the allegations against Mangione remain exactly that. He and his legal team have pleaded not guilty to all charges.

The Evidence Fight That Could Decide Everything

Mangione’s trial in New York City has yet to begin, and there is not even a firm date, but it has already become clear that the proceedings will be neither quick nor simple. The prosecution and defense have been embroiled in a multi-day pretrial hearing, in which both sides argue over which pieces of evidence should be admitted.

Chief among those concerns, Mangione’s defense team has requested that several of his alleged statements — including the note found on his person — not be used as evidence. According to the defense, the search of Mangione’s backpack was illegal because officers lacked a warrant at the time of the seizure, and statements he made at the scene should be inadmissible because, although he was technically free to leave, officers physically obstructed his path away from the scene.

Those requests are not particularly likely to be granted. According to legal experts, it is more likely that Mangione’s verbal and written statements will be allowed in full, as evidence against him. Prosecutors also intend to use the recording of the 911 call that led to his arrest, images of Mangione allegedly moving around New York prior to the killing, and the footage of Thompson’s shooting itself.

Identification, Charges, and the Stakes

Separately, the defense hopes to stop the prosecution from relying on non-eyewitness identification — meaning witnesses could not testify that Mangione was present in a certain place or at a certain time, including in the shooting depicted on video, unless they can attest that they saw him personally. If the judge allows that exception, it will be much harder for prosecutors to tie Mangione conclusively to the video of Thompson’s shooting, where his full face is never visible. Whatever the judge ultimately decides, the range of available evidence may dictate whether Mangione is found guilty on all counts, or evades at least some of the charges.

At present, Mangione faces charges of second-degree murder and eight counts of criminal possession of a weapon in the state of New York. Once this trial concludes, he will have to face a set of federal charges, including using a firearm to commit murder, interstate stalking and stalking through use of interstate facilities resulting in death, and using a firearm equipped with a silencer to commit a crime. He will also have to answer charges in Pennsylvania, where he was apprehended: forgery, false identification to law enforcement, carrying a gun without a license, and possessing an “instrument of crime.”

He has already avoided one set of charges — an attempt in New York state to charge him with murder in furtherance of terrorism. If he is found guilty, Mangione faces up to life imprisonment on the state-level charges, while US Attorney General Pam Bondi has instructed federal prosecutors to seek the death penalty.

A Trial That Has Become a Referendum

All outward indicators suggest that public support for Mangione remains. On the first day of his pretrial proceedings, demonstrators gathered outside the Manhattan courthouse, while a pair of vans drove through the surrounding streets displaying both Mangione’s likeness and statistics that reflect quite poorly on the healthcare industry. Online, the pretrial appearance generated a whole new round of commentary, and that conversation is only expected to swell in size and engagement as the trial gets underway.

Beyond the shooting of Brian Thompson, Mangione’s supporters have frequently expressed frustration at the way he has been treated while in custody, deriding both the decision to pursue terrorism charges against him and the staging of a highly elaborate perp walk, which they cast as attempts to politicize the trial and gin up sympathy for UnitedHealth Group. Mangione’s actions, and his fate during and after trial, have become as polarizing as anything else in American political discourse — and, depending on where you look, he has become anything from a sex symbol, to a V-for-Vendetta-style role model, to a misguided young criminal, to a cold-blooded terrorist.

For that reason, jury selection is expected to be very challenging when that process eventually takes place, as both the defense and the prosecution will have to agree on jurors who can credibly say they have somehow avoided forming any opinion on the case beforehand.

What to Expect Next

As the United States gears up for the trial, expect widespread media coverage — both of the Mangione case directly, and of its larger implications for the nation’s healthcare system. The trial will likely take place as America builds up to its midterm election season, in a fraught political environment that has been marred by recent, overt acts of political violence.

A verdict in either direction may become a referendum on something far larger than the guilt or innocence of one man. Right now, Americans of every political persuasion are likely to pay attention. And, as ever, what happens in the United States tends to generate major ripple effects across the globe. A trial like this one will probably be no different.

Simon Whistler
Presented by

Simon Whistler

Simon Whistler is one of YouTube's most prolific educational creators. HomeFronts is his deep dive into geopolitics, modern conflict, military history, and the civilian and societal dimensions of global events.

Frequently Asked Questions

Who was Brian Thompson? He was the chief executive of UnitedHealthcare, America’s largest health insurer, and had worked for the company for over two decades. Despite leading a corporation that is a fixture in American life, he was far from a public-facing figure. He was shot outside a Midtown Manhattan hotel on December 4, 2024, and pronounced dead at 7:12 AM at Mount Sinai Hospital.

What is Luigi Mangione charged with? In New York state, he faces second-degree murder and eight counts of criminal possession of a weapon. He also faces federal charges, including using a firearm to commit murder, interstate stalking resulting in death, and using a silencer-equipped firearm to commit a crime. In Pennsylvania, where he was apprehended, he faces forgery, false identification to law enforcement, carrying a gun without a license, and possessing an “instrument of crime.”

What were the words etched on the bullet casings? Investigators found three casings etched with the words “delay,” “deny,” and “depose.” Two of those — “delay” and “deny” — were already familiar to patients and healthcare professionals as language associated with insurance claim denials.

Why is public reaction to the case so unusual? Many Americans hold deep anger toward the US healthcare system, and toward UnitedHealth Group in particular over allegations of denied care and corporate misconduct. While the vast majority condemned the killing itself, polling found that nearly seventy percent blamed claim denials or insurer profiteering for deaths, and an Emerson College poll found forty-one percent of young respondents called the killing “acceptable or somewhat acceptable.” Crowdfunding for Mangione’s defense has topped a million dollars.

What is the pretrial fight about? The defense wants several of Mangione’s alleged statements excluded, arguing the search of his backpack was warrantless and that statements at the scene were made while officers obstructed his exit. Legal experts consider it more likely the statements will be admitted in full. The defense also seeks to bar non-eyewitness identification, which could make it harder to tie Mangione to the shooting footage, where his full face is never visible.

What penalties does Mangione face? If found guilty, he faces up to life imprisonment on the state-level charges. Separately, US Attorney General Pam Bondi has instructed federal prosecutors to seek the death penalty. He has already avoided one attempt by New York state to charge him with murder in furtherance of terrorism.

Has Mangione admitted to the killing? No. Mangione and his legal team have pleaded not guilty to all charges. The statements attributed to him, and the allegations against him, remain allegations that have not been proven in court.

Sources

Related Articles

Fronts Insider

Go deeper than the headlines.

Fronts Insider turns the strongest HomeFronts reporting into a fuller intelligence product: member-only briefings, sharper strategic context, and premium analysis built for readers who want more than headlines.

Inside the membership

  • Full access to all premium articles
  • Enjoy premium videos and long-form analysis
  • Get exclusive insights through member-only context and field notes
  • Support independent geopolitics and conflict coverage
Explore Fronts Insider